cyclin dependent kinase inhibitor 1B
| GO Term | Evidence Code | PMID |
|---|---|---|
| response to amino acid | ||
| response to peptide hormone | ||
| positive regulation of protein catabolic process | ||
| negative regulation of cyclin-dependent protein serine/threonine kinase activity | ||
| positive regulation of DNA replication |
| InterPro |
|---|
| Cyclin-dependent kinase inhibitor domain superfamily |
| Cyclin-dependent kinase inhibitor domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050908 | myelodysplastic syndrome | |
| DOID:0080137 | multiple endocrine neoplasia type 4 | |
| DOID:1612 | breast cancer | |
| DOID:9119 | acute myeloid leukemia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025